SOUTH SAN FRANCISCO, CA--(Marketwire - September 29, 2008) - Limerick NeuroSciences, Inc., a privately held biopharmaceutical company, today announced its name change to Limerick BioPharma. Limerick has identified a proprietary means of improving existing therapeutics by chemically modulating bioavailability and is applying this technology to the development of safer and more potent pharmaceuticals. The company also introduced changes to its website, which presents current information about Limerick BioPharma and provides an overview of its proprietary Efflux Pump Activators. The new website can be found at http://www.limerickbio.com.
